GlassScriptPhysician profile
Melissa L Sheldon
NPI 1689223141
$1,376.06
in general payments reported to CMS, 2019-2025
27 companies · $128 in 2025
The $128 reported for 2025 was less than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $321 · 2023: $489 · 2024: $438 · 2025: $128.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,055.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,054.97 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $184.16 | 2022-2025 | Wegovy, Ozempic, Rybelsus |
| Pfizer INC. | $168.34 | 2023-2025 | |
| Revance Therapeutics, INC. | $134.37 | 2024 | Daxxify |
| Lilly USA, LLC | $123.54 | 2023-2024 | Mounjaro, Zepbound |
| Merz North America, INC. | $122.55 | 2023 | |
| Myovant Sciences INC. | $121.52 | 2022 | |
| Scynexis, INC. | $68.80 | 2022 | |
| Otsuka America Pharmaceutical, INC. | $51.94 | 2023-2024 | Rexulti |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $40.64 | 2022-2023 | Xifaxan |
| Boehringer Ingelheim Pharmaceuticals, INC. | $36.39 | 2023 | Jardiance |
| Glaxosmithkline, LLC. | $32.57 | 2023 | Trelegy Ellipta, Arexvy |
| Amgen INC. | $29.90 | 2023 | Evenity, Prolia |
| Tactile Systems Technology INC | $23.21 | 2023 | Entre Plus, Flexitouch Plus |
| Abbvie INC. | $19.76 | 2022 | |
| Radius Health, INC. | $19.73 | 2023 | Tymlos |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Dexcom, INC. | $19.30 | 2025 | Dexcom G6 Transmitter |
| Insulet Corporation | $18.88 | 2024 | Omnipod |
| Therapeuticsmd, INC. | $18.60 | 2022 | |
| Mission Pharmacal Company | $18.36 | 2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $18.11 | 2023 | |
| Nevro Corp. | $18.03 | 2023 | Senza |
| Exact Sciences Corporation | $16.25 | 2023 | Cologuard Collection Kit |
| Boston Scientific Corporation | $15.97 | 2025 | General - Therapies |
| Philips North America LLC | $14.94 | 2025 | Ecc Solutions |
| Shield Therapeutics INC | $14.24 | 2022 | |
| Mylan Specialty L.P. | $13.62 | 2023 | Yupelri |
| Organon LLC | $12.34 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Melissa Sheldon listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.